Coya Therapeutics, Inc. Common Stock COYA
HEALTHCARE · BIOTECHNOLOGYi
Market datapartial · fetched 2026-11-11T14:51:21.284Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:33:24.657060969Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-11T14:51:19.606242+00:00
Coya Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 3.29 | 648.8% | 71.7% | |||
| 25Δ | 3.63 | 584.4% | 62.8% | |||
| 30Δ | 3.96 | 519.9% | 53.9% | |||
| 35Δ | 4.30 | 455.4% | 45.1% | |||
| 40Δ | 4.64 | 391.0% | 36.2% | |||
| 45Δ | 4.97 | 326.5% | 27.4% | |||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | ||||||
| 65Δ | ||||||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.29
- IV
- 648.8%
- B/E move
- 71.7%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.63
- IV
- 584.4%
- B/E move
- 62.8%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.96
- IV
- 519.9%
- B/E move
- 53.9%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.30
- IV
- 455.4%
- B/E move
- 45.1%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.64
- IV
- 391.0%
- B/E move
- 36.2%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.97
- IV
- 326.5%
- B/E move
- 27.4%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
CRBP
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target the endocannabinoid…
More →CRBU
Description unavailable
More →CRDF
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.
More →CRMD
CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in…
More →CRSP
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug,…
More →CRVS
Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. The company is…
More →